|4Mar 18, 8:01 AM ET

Bukofzer Stan 4

4 · Assertio Therapeutics, Inc · Filed Mar 18, 2019

Insider Transaction Report

Form 4
Period: 2019-03-14
Bukofzer Stan
Chief Medical Officer & SVP***
Transactions
  • Purchase

    Common Stock

    2019-03-14$4.13/sh+5,000$20,6585,000 total
Footnotes (1)
  • [F1]The price reported is a weighted average purchase price. The shares were purchased in multiple same-way transactions on March 14, 2019 at prices ranging from $4.123 to $4.133 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock purchased at each separate price.

Documents

1 file
  • 4
    wf-form4_155291049510979.xmlPrimary

    FORM 4